Becton Dickinson Operating Margin 2010-2023 | BDX

Current and historical operating margin for Becton Dickinson (BDX) over the last 10 years. The current operating profit margin for Becton Dickinson as of December 31, 2023 is 17.89%.
Becton Dickinson Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-12-31 $19.49B $1.96B 10.07%
2023-09-30 $19.37B $2.11B 10.90%
2023-06-30 $19.05B $2.25B 11.81%
2023-03-31 $18.81B $2.24B 11.90%
2022-12-31 $18.74B $2.18B 11.62%
2022-09-30 $18.87B $2.28B 12.10%
2022-06-30 $18.41B $1.88B 10.20%
2022-03-31 $18.38B $1.83B 9.97%
2021-12-31 $18.53B $1.70B 9.17%
2021-09-30 $19.13B $2.25B 11.77%
2021-06-30 $18.57B $1.85B 9.96%
2021-03-31 $17.82B $1.72B 9.64%
2020-12-31 $17.16B $1.65B 9.63%
2020-09-30 $16.07B $0.91B 5.67%
2020-06-30 $16.92B $1.34B 7.93%
2020-03-31 $17.41B $1.61B 9.23%
2019-12-31 $17.36B $1.38B 7.92%
2019-09-30 $17.29B $1.76B 10.18%
2019-06-30 $17.11B $2.22B 13.00%
2019-03-31 $17.04B $2.11B 12.38%
2018-12-31 $17.06B $2.16B 12.66%
2018-09-30 $15.98B $1.51B 9.44%
2018-06-30 $14.75B $1.42B 9.66%
2018-03-31 $13.50B $0.69B 5.10%
2017-12-31 $12.25B $0.95B 7.73%
2017-09-30 $12.09B $1.52B 12.59%
2017-06-30 $12.16B $1.13B 9.28%
2017-03-31 $12.32B $1.87B 15.16%
2016-12-31 $12.42B $1.89B 15.20%
2016-09-30 $12.48B $1.43B 11.46%
2016-06-30 $12.31B $1.63B 13.22%
2016-03-31 $12.23B $1.25B 10.21%
2015-12-31 $11.22B $1.08B 9.60%
2015-09-30 $10.28B $1.07B 10.45%
2015-06-30 $9.42B $1.18B 12.52%
2015-03-31 $8.46B $1.49B 17.60%
2014-12-31 $8.48B $1.58B 18.59%
2014-09-30 $8.45B $1.61B 19.01%
2014-06-30 $8.35B $1.28B 15.36%
2014-03-31 $8.24B $1.24B 15.06%
2013-12-31 $8.17B $1.24B 15.19%
2013-09-30 $8.05B $1.26B 15.58%
2013-06-30 $7.92B $1.57B 19.79%
2013-03-31 $7.85B $1.61B 20.53%
2012-12-31 $7.78B $1.61B 20.74%
2012-09-30 $7.71B $1.56B 20.21%
2012-06-30 $7.61B $1.53B 20.14%
2012-03-31 $7.58B $1.53B 20.20%
2011-12-31 $7.57B $1.59B 20.97%
2011-09-30 $7.58B $1.66B 21.94%
2011-06-30 $7.34B $1.62B 22.01%
2011-03-31 $7.22B $1.59B 22.05%
2010-12-31 $7.10B $1.57B 22.07%
2010-09-30 $7.12B $1.58B 22.22%
2010-06-30 $7.22B $1.65B 22.79%
2010-03-31 $7.21B $1.66B 22.95%
2009-12-31 $7.14B $1.60B 22.44%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.638B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00